This page will only be updated if Exeltis anticipate stock constraint at a patient level.
This page will not be updated until there is a change in the stock status.
Stock levels are monitored regularly.
The date updated reflects the last time the page changed.
Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Exeltis UK Limited on 01494 411775 or by email to uk.medinfo@exeltis.com
Latest
Latest
Company info
